Latest filing published 01 Aug 2012 for HEMAGEN DIAGNOSTICS INC, €211.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
William P. Hales: trading record in brief
William P. Hales discloses dealings in Hemagen Diagnostics Inc to SEC (Form 4). We count 3 filings; the first trade dates from 30 August 2006 and the latest from 31 July 2012.
Purchases make up the whole of the open-market record (3 purchases, €11k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2012 alone, the filings show 1 purchase and no sales.
The median purchase comes to €211.
The record was last updated on 1 August 2012 with an open-market purchase (€211) in Hemagen Diagnostics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William P. Hales
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,800 shares@ US$0.024Common StockSEC:0001140361-12-034551:0Canonical exit: 29 Oct 2012 (T+90)
- 5,300 shares@ US$0.05Common StockSEC:0001140361-11-021388:0Canonical exit: 5 Jul 2011 (T+90)
- 50,000 shares@ US$0.26Common StockSEC:0000892251-06-000584:0Canonical exit: 28 Nov 2006 (T+90)
3 of 3 declarations